NCT01496313 2025-10-03
To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer
Sanofi
Phase 4 Completed
Clinical Trials
4 trialsNCT01896479 2025-09-02
EXAMINER
Exelixis
Phase 4 Active not recruiting
NCT05830500 2023-07-25
Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 4 Recruiting
NCT01915485 2016-09-07
Radiolabeled Molecules for Medullary Thyroid Cancer
Instituto Nacional de Cancer, Brazil
Phase 4 Unknown